Grace Therapeutics, Inc.
New Filing
CIK: 0001444192·Pharmaceuticals·DELAWARE·Filed: Aug 10, 2026
Total Offering
$9,999,998
Amount Sold
$9,999,998
Investors
9
First Sale
Aug 4, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Prashant Kohli | |
| Vimal Kavuru | |
| Robert J. DelAversano | |
| A. Brian Davis | |
| S. George Kottayil | |
| Edward Neugeboren | |
| Dr. R. Loch Macdonald | |
| Amresh Kumar |
Company
SEC Filing
0001123292-26-001084
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free